Phase IV Study of Enteric-Coated Mycophenolate Sodium in Combination With Tacrolimus in Renal Transplant Patient.

Trial Profile

Phase IV Study of Enteric-Coated Mycophenolate Sodium in Combination With Tacrolimus in Renal Transplant Patient.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Mycophenolate sodium; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 07 May 2012 Actual end date (December 2008) added as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Actual number of patients (18) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top